Brief: CombiGene Enters Into Collaboration Agreement With Zyneyro

Larkberget AB

09/01/2023 07:02

Jan 9 (Reuters) - Combigene AB  COMBI.ST :
    * COMBIGENE ENTERS INTO COLLABORATION AGREEMENT WITH ZYNEYRO
FOR
THE DEVELOPMENT OF A UNIQUE CONCEPT FOR EFFECTIVE RELIEF OF
CHRONIC PAIN
    * AGREEMENT WITH ZYNEYRO IS A COOPERATION AGREEMENT THAT
MEANS
THAT ZYNEYRO AND COMBIGENE SHARE PROJECT'S COSTS AND REVENUES
EQUALLY
    * ACCORDING TO AGREEMENT COMBIGENE WILL PAY ZYNEYRO AN
UPFRONT OF
DKK 5 MILLION IN CONNECTION WITH SIGNING OF AGREEMENT
    * COMBIGENE HAS ALSO COMMITTED TO PAY AN ADDITIONAL MAXIMUM
OF DKK
11.4 MILLION IN CONTINUED DEVELOPMENT SUPPORT TOWARDS CLINICAL
PHASE 1
    * PEPTIDE-BASED TREATMENT IS EXPECTED TO BE READY FOR FIRST
HUMAN
DOSING IN 2025

Source text for Eikon:  ID:nMFNZY5nq 
Further company coverage:  COMBI.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))